As in the case of cohesin mutations, the unusually high frequency found in ML-DS suggests that the partial absence of CTCF function may cooperate with the dosage imbalance of chromosome 21 genes, with specific megakaryocytic transcriptional regulators, or with both. This evidence concerns the gene CTCF and Dravet syndrome.